GlassScriptPhysician profile
Erin C Jiminez
NPI 1073945705
$1,701.57
in general payments reported to CMS, 2019-2025
9 companies · $612 in 2025
The $612 reported for 2025 was more than what 78% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $148 · 2022: $621 · 2023: $269 · 2024: $51.33 · 2025: $612.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $933.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $933.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $513.08 | 2021-2025 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $371.01 | 2021-2023 | Breztri |
| Abbvie INC. | $250.00 | 2025 | |
| Sanofi-Aventis U.S. LLC | $246.83 | 2021-2023 | |
| Lilly USA, LLC | $110.53 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $103.36 | 2022 | |
| Blueprint Medicines Corporation | $56.44 | 2022-2023 | Ayvakit |
| Inspire Medical Systems, INC. | $25.75 | 2025 | Inspire |
| Exact Sciences Corporation | $24.57 | 2025 | The Cologuard Plus Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Jiminez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.